Peak6 Investments LLC Eagle Pharmaceuticals, Inc. Put Options Transaction History

Peak6 Investments LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2019 Nov 08, 2019	SELL	$53.25 - $59.98 $1.3 Million - $1.46 Million	-24,400 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $1.15 Million - $1.44 Million	-24,600 Reduced 50.2%	24,400 $1.36 Million
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $417,527 - $559,656	10,800 Added 28.27%	49,000 $2.47 Million
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $1.4 Million - $2.59 Million	38,200 New	38,200 $1.54 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.